Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche
Authors
Keywords
-
Journal
ONCOGENE
Volume 36, Issue 20, Pages 2846-2856
Publisher
Springer Nature
Online
2016-12-20
DOI
10.1038/onc.2016.436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Novel Small-Molecule CX3CR1 Antagonist Impairs Metastatic Seeding and Colonization of Breast Cancer Cells
- (2016) F. Shen et al. MOLECULAR CANCER RESEARCH
- Therapeutic approaches to enhance natural killer cell cytotoxicity against cancer: the force awakens
- (2015) Richard W. Childs et al. NATURE REVIEWS DRUG DISCOVERY
- A Preclinical Model of Inflammatory Breast Cancer to Study the Involvement of CXCR4 and ACKR3 in the Metastatic Process
- (2015) Roberto Wurth et al. Translational Oncology
- Bioengineered Implantable Scaffolds as a Tool to Study Stromal-Derived Factors in Metastatic Cancer Models
- (2014) F. Bersani et al. CANCER RESEARCH
- Modulation of Androgen Receptor by FOXA1 and FOXO1 Factors in Prostate Cancer
- (2014) Yu Zhao et al. International Journal of Biological Sciences
- Interleukin-1 Promotes Skeletal Colonization and Progression of Metastatic Prostate Cancer Cells with Neuroendocrine Features
- (2013) Q. Liu et al. CANCER RESEARCH
- Selection and adaptation during metastatic cancer progression
- (2013) Christoph A. Klein NATURE
- Tumour heterogeneity in the clinic
- (2013) Philippe L. Bedard et al. NATURE
- ‘Cancer associated fibroblasts’ – more than meets the eye
- (2013) Shalom Madar et al. TRENDS IN MOLECULAR MEDICINE
- Cancer-Associated Fibroblasts Drive the Progression of Metastasis through both Paracrine and Mechanical Pressure on Cancer Tissue
- (2012) G. S. Karagiannis et al. MOLECULAR CANCER RESEARCH
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- Strategies for the discovery and development of therapies for metastatic breast cancer
- (2012) Bedrich L. Eckhardt et al. NATURE REVIEWS DRUG DISCOVERY
- Cancer-Stimulated Mesenchymal Stem Cells Create a Carcinoma Stem Cell Niche via Prostaglandin E 2 Signaling
- (2012) Hua-Jung Li et al. Cancer Discovery
- Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets
- (2011) H. Beltran et al. Cancer Discovery
- RANKL-independent human osteoclast formation with APRIL, BAFF, NGF, IGF I and IGF II
- (2010) F. Hemingway et al. BONE
- Why not treat human cancer with interleukin-1 blockade?
- (2010) Charles A. Dinarello CANCER AND METASTASIS REVIEWS
- Bone-specific growth inhibition of prostate cancer metastasis by Atrasentan
- (2010) Justin M. Drake et al. CANCER BIOLOGY & THERAPY
- Reciprocal Activation of Prostate Cancer Cells and Cancer-Associated Fibroblasts Stimulates Epithelial-Mesenchymal Transition and Cancer Stemness
- (2010) E. Giannoni et al. CANCER RESEARCH
- The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression
- (2010) Ankur Sharma et al. JOURNAL OF CLINICAL INVESTIGATION
- S100A4 and Metastasis
- (2009) Kjetil Boye et al. AMERICAN JOURNAL OF PATHOLOGY
- Effect of pro-inflammatory cytokine stimulation on human breast cancer: Implications of chemokine receptor expression in cancer metastasis
- (2009) Julio E. Valdivia-Silva et al. CANCER LETTERS
- Neuroendocrine differentiation in the progression of prostate cancer
- (2009) Akira Komiya et al. INTERNATIONAL JOURNAL OF UROLOGY
- Integrins in prostate cancer progression
- (2008) H. L. Goel et al. ENDOCRINE-RELATED CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started